The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study

Background: Vaccination is the most remarkable intervention in public health and is an effective strategy in controlling infectious diseases among infants. Objectives: The aim of this study was to compare the adverse events of Pentavalent vaccine and DPT vaccine in two- to six-month-old infants in I...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Zaher Khazaei, Ghobad Moradi, Seyed Mohsen Zahraei, Mohammad Mehdi Gouya, Elham Goodarzi, Fateme Yaghini, Daem Roshani
Formato: article
Lenguaje:EN
Publicado: Ubiquity Press 2020
Materias:
Acceso en línea:https://doaj.org/article/652a60ef47c04953916169d133edbede
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:652a60ef47c04953916169d133edbede
record_format dspace
spelling oai:doaj.org-article:652a60ef47c04953916169d133edbede2021-12-02T11:37:53ZThe Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study2214-999610.5334/aogh.2449https://doaj.org/article/652a60ef47c04953916169d133edbede2020-02-01T00:00:00Zhttps://annalsofglobalhealth.org/articles/2449https://doaj.org/toc/2214-9996Background: Vaccination is the most remarkable intervention in public health and is an effective strategy in controlling infectious diseases among infants. Objectives: The aim of this study was to compare the adverse events of Pentavalent vaccine and DPT vaccine in two- to six-month-old infants in Iran. Methods: This is an analytical cross-sectional study in which healthy infants aged two to six months, having received DPT vaccine in 2013 and Pentavalent vaccine in 2015, were studied for any experienced adverse events related to these vaccines. Percentage, mean, standard deviation and chi-square tests were used to describe and analyze the data (p < 0.05). Findings: The results showed that 10,464 and 17,561 adverse events, which were associated with DPT vaccine and Pentavalent vaccine respectively, were recorded in the infants who received these vaccines throughout Iran. Mazandaran, Qazvin and Golestan provinces reported the highest number of adverse events, respectively (15.74%, 11.25%, and 9.12%). Moreover, Pentavalent vaccine seemed to have more recorded adverse events compared to DPT, high fever had the highest record rate for DPT vaccine (47.4%) and mild localized complications was the highest for Pentavalent vaccines (31.68%). There was a significant relationship between the kind of vaccine and the type of reaction, adverse event categorization and the country that produced the vaccine (p < 0.05). Conclusion: Severe localized adverse events including high fever, vomiting, diarrhea and restlessness seemed to be less in Pentavalent vaccine compared to DPT vaccine. Therefore, substituting Pentavalent vaccine for DPT vaccine in infants seems to reduce the adverse events among them.Zaher KhazaeiGhobad MoradiSeyed Mohsen ZahraeiMohammad Mehdi GouyaElham GoodarziFateme YaghiniDaem RoshaniUbiquity PressarticleInfectious and parasitic diseasesRC109-216Public aspects of medicineRA1-1270ENAnnals of Global Health, Vol 86, Iss 1 (2020)
institution DOAJ
collection DOAJ
language EN
topic Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
spellingShingle Infectious and parasitic diseases
RC109-216
Public aspects of medicine
RA1-1270
Zaher Khazaei
Ghobad Moradi
Seyed Mohsen Zahraei
Mohammad Mehdi Gouya
Elham Goodarzi
Fateme Yaghini
Daem Roshani
The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study
description Background: Vaccination is the most remarkable intervention in public health and is an effective strategy in controlling infectious diseases among infants. Objectives: The aim of this study was to compare the adverse events of Pentavalent vaccine and DPT vaccine in two- to six-month-old infants in Iran. Methods: This is an analytical cross-sectional study in which healthy infants aged two to six months, having received DPT vaccine in 2013 and Pentavalent vaccine in 2015, were studied for any experienced adverse events related to these vaccines. Percentage, mean, standard deviation and chi-square tests were used to describe and analyze the data (p < 0.05). Findings: The results showed that 10,464 and 17,561 adverse events, which were associated with DPT vaccine and Pentavalent vaccine respectively, were recorded in the infants who received these vaccines throughout Iran. Mazandaran, Qazvin and Golestan provinces reported the highest number of adverse events, respectively (15.74%, 11.25%, and 9.12%). Moreover, Pentavalent vaccine seemed to have more recorded adverse events compared to DPT, high fever had the highest record rate for DPT vaccine (47.4%) and mild localized complications was the highest for Pentavalent vaccines (31.68%). There was a significant relationship between the kind of vaccine and the type of reaction, adverse event categorization and the country that produced the vaccine (p < 0.05). Conclusion: Severe localized adverse events including high fever, vomiting, diarrhea and restlessness seemed to be less in Pentavalent vaccine compared to DPT vaccine. Therefore, substituting Pentavalent vaccine for DPT vaccine in infants seems to reduce the adverse events among them.
format article
author Zaher Khazaei
Ghobad Moradi
Seyed Mohsen Zahraei
Mohammad Mehdi Gouya
Elham Goodarzi
Fateme Yaghini
Daem Roshani
author_facet Zaher Khazaei
Ghobad Moradi
Seyed Mohsen Zahraei
Mohammad Mehdi Gouya
Elham Goodarzi
Fateme Yaghini
Daem Roshani
author_sort Zaher Khazaei
title The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study
title_short The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study
title_full The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study
title_fullStr The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study
title_full_unstemmed The Comparison of the Adverse Events of Pentavalent Vaccine and DPT Vaccine in 2–6 Months Infants in Iran: A National Study
title_sort comparison of the adverse events of pentavalent vaccine and dpt vaccine in 2–6 months infants in iran: a national study
publisher Ubiquity Press
publishDate 2020
url https://doaj.org/article/652a60ef47c04953916169d133edbede
work_keys_str_mv AT zaherkhazaei thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT ghobadmoradi thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT seyedmohsenzahraei thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT mohammadmehdigouya thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT elhamgoodarzi thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT fatemeyaghini thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT daemroshani thecomparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT zaherkhazaei comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT ghobadmoradi comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT seyedmohsenzahraei comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT mohammadmehdigouya comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT elhamgoodarzi comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT fatemeyaghini comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
AT daemroshani comparisonoftheadverseeventsofpentavalentvaccineanddptvaccinein26monthsinfantsinirananationalstudy
_version_ 1718395762968100864